Work

Individualizing Targets and Tactics for High-Risk Patients With Type 2 Diabetes

Year: 2012
Type: article
Abstract: Four years ago, the Action to ControlCardiovascular Risk in Diabetes(ACCORD) trial was stopped early as the result of increased mortality asso-ciated with intensive glycemic treatment of a population with type 2 diabetes (T2DM) and high cardiovascular (CV) risk (1). Further reports have appeared from ACCORD (2) and other studies of high-risk populations, notably the Action in Di-
Language: English
Field: Medicine
Open Access status: hybrid
OpenAlex ID: W2133279372
FWCI: 6.384
Cites: 52
Cited by: 56
Related to: 9